Therapy-related myeloid neoplasms in 39 Korean patients: A single institution experience

Annals of Laboratory Medicine

Volumn 33, Issue 2, 2013, Pages 97-104

  Huh, Hee Jae ^a   Lee, Soo Hyun ^a   Yoo, Keon Hee ^a   Sung, Ki Woong ^a   Koo, Hong Hoe ^a   Kim, Kihyun ^a   Jang, Jun Ho ^a   Jung, Chulwon ^a   Kim, Sun Hee ^a   Kim, Hee Jin ^a  

^a Samsung Medical Center   (South Korea)

Author keywords

Acute myeloid leukemia; Cytogenetics; Korea; Myelodysplastic syndrome; Therapy related neoplasms

Indexed keywords

EID: 84876103345     PISSN: 22343806     EISSN: 22343814     Source Type: Journal    
DOI: 10.3343/alm.2013.33.2.97     Document Type: Article

References (28)

1. Swerdlow SH, Campo E, et al. eds. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press, 2008:110.
2. Michels SD, McKenna RW, Arthur DC, Brunning RD. Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases. Blood 1985;65:1364-72.
3. Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, et al. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol 1986;4:325-45.
4. Smith SM, Le Beau MM, Huo D, Karrison T, Sobecks RM, Anastasi J, et al. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood 2003;102:43-52.
5. Rowley JD and Olney HJ. International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: overview report. Genes Chromosomes Cancer 2002;33:331-45.
6. Rund D, Krichevsky S, Bar-Cohen S, Goldschmidt N, Kedmi M, Malik E, et al. Therapy-related leukemia: clinical characteristics and analysis of new molecular risk factors in 96 adult patients. Leukemia 2005;19:1919-28.
7. Pedersen-Bjergaard J. Insights into leukemogenesis from therapy-related leukemia. N Engl J Med 2005;352:1591-4.
8. Pedersen-Bjergaard J, Specht L, Larsen SO, Ersbøll J, Struck J, Hansen MM, et al. Risk of therapy-related leukaemia and preleukaemia after Hodgkin's disease. Relation to age, cumulative dose of alkylating agents, and time from chemotherapy. Lancet 1987;2:83-8.
9. Thirman MJ and Larson RA. Therapy-related myeloid leukemia. Hematol Oncol Clin North Am 1996;10:293-320.
10. Singh ZN, Huo D, Anastasi J, Smith SM, Karrison T, Le Beau MM, et al. Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant. Am J Clin Pathol 2007;127:197-205.
11. Mauritzson N, Albin M, Rylander L, Billstrom R, Ahlgren T, Mikoczy Z, et al. Pooled analysis of clinical and cytogenetic features in treatmentrelated and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001. Leukemia 2002;16:2366-78.
12. Pedersen-Bjergaard J, Christiansen DH, Desta F, Andersen MK. Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia. Leukemia 2006;20:1943-9.
13. Estey E and Döhner H. Acute myeloid leukaemia. Lancet 2006;368:1894-907.
14. Shaffer LG, Slovak ML, et al. eds. ISCN 2009: An International System of Human Cytogenetic Nomenclature. Basel: Karger, 2009.
15. Arana-Yi C, Block AW, Sait SN, Ford LA, Barcos M, Baer MR. Therapyrelated myelodysplastic syndrome and acute myeloid leukemia following treatment of acute myeloid leukemia: possible role of cytarabine. Leuk Res 2008;32:1043-8.
16. Rund D and Ben-Yehuda D. Therapy-related leukemia and myelodysplasia: evolving concepts of pathogenesis and treatment. Hematology 2004;9:179-87.
17. Shim H, Chi HS, Jang S, Seo EJ, Park CJ, Lee JH, et al. Therapy-related acute leukemia in breast cancer patients: twelve cases treated with a topoisomerase inhibitor. Korean J Hematol 2010;45:177-82.
18. Hur M, Lee DS, Shin HY, Ahn HS, Kim BK, Cho HI. Four cases of therapy-related leukemia. J Korean Med Sci 1999;14:327-9.
19. Lee SY, Kim M, Lim J, Kim Y, Han K, Kim SY, et al. A case of therapyrelated acute myeloid leukemia associated with inv(16). Korean J Lab Med 2007;27:19-21.
20. Seo YI, Park R, Choi TY, Shin JW, Won JH, Park HS, et al. A case of therapy-related acute monocytic leukemia following low-dose of etoposide treatment for hemophagocytic lymphohistiocytosis. Korean J Lab Med 2007;27:244-7.
21. Park TS, Cheong JW, Song J, Choi Jr. Therapy-related myelodysplastic syndrome with der(17)t(12;17)(q13;p13) as a new recurrent cytogenetic abnormality after treatment for chronic lymphocytic leukemia. Leuk Res 2009;33:1001-4.
22. Jung CL, Kim HJ, Kim DH, Huh HJ, Song MJ, Kim SH. CKIT mutation in therapy-related acute myeloid leukemia with MLLT3/MLL chimeric transcript from t(9;11)(p22;q23). Ann Clin Lab Sci 2011;41:193-6.
23. Kim YG, Cho SY, Park TS, Oh SH, Yoon HJ. Therapy-related myelodysplastic syndrome/acute myeloid leukemia with del(7)(q22) in a patient with de novo AML. Ann Clin Lab Sci 2011;41:79-83.
24. Kwon A, Park JY, Kwon JH, Song HH, Shin KS, Lee YK, et al. A case of therapy-related myeloid neoplasm after successful treatment of acute promyelocytic leukemia. Lab Med Online 2011;1:227-31.
25. Chandra P, Luthra R, Zuo Z, Yao H, Ravandi F, Reddy N, et al. Acute myeloid leukemia with t(9;11)(p21-22;q23): common properties of dysregulated ras pathway signaling and genomic progression characterize de novo and therapy-related cases. Am J Clin Pathol 2010;133:686-93.
26. Larson RA. Therapy-related myeloid neoplasms. Haematologica 2009; 94:454-9.
27. Schoch C, Kern W, Schnittger S, Hiddemann W, Haferlach T. Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML. Leukemia 2004;18:120-5.
28. Kern W, Haferlach T, Schnittger S, Hiddemann W, Schoch C. Prognosis in therapy-related acute myeloid leukemia and impact of karyotype. J Clin Oncol 2004;22:2510-1.